Wednesday, June 10

Browsing: pCR

Survivors

CD39/PD-L1 Inhibition May Improve pCR Rate in Resectable NSCLC

By NewsCancerApril 21, 20260

Adding IPH5201, an investigational CD39 inhibitor, to perioperative durvalumab (Opdivo) and neoadjuvant chemotherapy produced a promising pathologic complete response (pCR)…

Survivors

Anbenitamab Injection Combo Meets pCR End Point in HER2+ Breast Cancer

By NewsCancerApril 1, 20260

Anbenitamab injection (KN026) and albumin-bound docetaxel (HB1801) met the pre-specificized primary end point of pathological complete response (pCR) rate, which…

Survivors

THP Yields Noninferior pCR vs TCbHP in HER2-Positive Early Breast Cancer

By NewsCancerMarch 4, 20260

The phase 3 neoCARHP trial (NCT04858529) found that investigator-selected taxane plus trastuzumab (Herceptin) and pertuzumab (Perjeta; THP) provided noninferior pathological…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes

How I Stopped Being the Victim of My Own Story

Actor Tyler Mane reveals he is having treatment for rare male breast cancer | US news

Browsing: pCR

CD39/PD-L1 Inhibition May Improve pCR Rate in Resectable NSCLC

Anbenitamab Injection Combo Meets pCR End Point in HER2+ Breast Cancer

THP Yields Noninferior pCR vs TCbHP in HER2-Positive Early Breast Cancer

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes

How I Stopped Being the Victim of My Own Story

Actor Tyler Mane reveals he is having treatment for rare male breast cancer | US news

Investigators Halt Phase 3 Trial of Sacituzumab Govitecan Combo in NSCLC

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes

How I Stopped Being the Victim of My Own Story

Actor Tyler Mane reveals he is having treatment for rare male breast cancer | US news

Investigators Halt Phase 3 Trial of Sacituzumab Govitecan Combo in NSCLC

Latest Post

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes

How I Stopped Being the Victim of My Own Story

Actor Tyler Mane reveals he is having treatment for rare male breast cancer | US news

Subscribe to Updates

What's Hot

Browsing: pCR